130 related articles for article (PubMed ID: 37547717)
1. Transcriptomic characterization revealed that METTL7A inhibits melanoma progression via the p53 signaling pathway and immunomodulatory pathway.
Zhang D; Zou T; Liu Q; Chen J; Xiao M; Zheng A; Zhang Z; Du F; Dai Y; Xiang S; Wu X; Li M; Chen Y; Zhao Y; Shen J; Chen G; Xiao Z
PeerJ; 2023; 11():e15799. PubMed ID: 37547717
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of METTL7A gene body regulates its transcriptional level in thyroid cancer.
Zhou S; Shen Y; Zheng M; Wang L; Che R; Hu W; Li P
Oncotarget; 2017 May; 8(21):34652-34660. PubMed ID: 28416772
[TBL] [Abstract][Full Text] [Related]
4. FOXN3 inhibits cell proliferation and invasion via modulating the AKT/MDM2/p53 axis in human glioma.
Wang C; Tu H; Yang L; Ma C; Hu J; Luo J; Wang H
Aging (Albany NY); 2021 Sep; 13(17):21587-21598. PubMed ID: 34511432
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer analysis reveals potential immunological and prognostic roles of METTL7A in human cancers.
Wang B; Jiang J; Luo D; Wang X
Sci Rep; 2024 Feb; 14(1):3476. PubMed ID: 38342956
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
7. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma.
Pan YQ; Xiao Y; Li Z; Tao L; Chen G; Zhu JF; Lv L; Liu JC; Qi JQ; Shao A
Front Oncol; 2022; 12():1071100. PubMed ID: 36620541
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomic analysis identifies novel regulators of methotrexate resistance in choriocarcinoma.
Jun F; Peng Z; Zhang Y; Shi D
Gynecol Oncol; 2020 Apr; 157(1):268-279. PubMed ID: 31955862
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
Liao Z; Zhao J; Yang Y
Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
[TBL] [Abstract][Full Text] [Related]
11. Evidence Based on an Integrative Analysis of Multi-Omics Data on METTL7A as a Molecular Marker in Pan-Cancer.
Liu Z; Chen Y; Shen T
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830565
[TBL] [Abstract][Full Text] [Related]
12. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
[TBL] [Abstract][Full Text] [Related]
13. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
14. ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract][Full Text] [Related]
15. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer.
Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y
Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
17. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
18. Mechanism of MicroRNA-708 Targeting BAMBI in Cell Proliferation, Migration, and Apoptosis in Mice With Melanoma via the Wnt and TGF-β Signaling Pathways.
Lu HJ; Yan J; Jin PY; Zheng GH; Zhang HL; Bai M; Wu DM; Lu J; Zheng YL
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756784. PubMed ID: 29466930
[TBL] [Abstract][Full Text] [Related]
19. The novel putative methyltransferase METTL7A as one prognostic biomarker potentially associated with immune infiltration in human renal cancer.
Yang Z; Zhang W; Li L; Hu N; Dong X; Chen Y; Cai W; Yin L; Liu F; Tang D; Dai Y
Heliyon; 2023 Apr; 9(4):e15371. PubMed ID: 37123902
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of MTHFD2 inhibits proliferation and migration of nasopharyngeal carcinoma cells through the ERK signaling pathway.
Wu S; Cai W; Shi Z; Ming X; Yang X; Zhou Y; Chen X; Yang M
Biochem Biophys Res Commun; 2022 Jul; 614():47-55. PubMed ID: 35567943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
